多巴胺基操纵影响运动速度的调制和元调制:来自两个药理干预的证据
Lydia J Hickman1, Sophie L Sowden-Carvalho2, Dagmar S Fraser2
1Centre for Human Brain Health, School of Psychology, University of Birmingham, B15 2TT, United Kingdom; MRC Cognition and Brain Sciences Unit, University of Cambridge, 15 Chaucer Road, CB2 7EF, United Kingdom.
Behavioural brain research
|August 25, 2024
概括
多巴胺不仅会影响平均运动速度,还会影响复杂运动中的速度变化. 低多巴胺水平会降低自然运动中的速度,速度调节和速度元调节.
科学领域:
- 神经科学是一个神经科学.
- 发动机控制器的控制器
- 认知科学 认知科学
背景情况:
- 多巴胺与平均运动速度有关.
- 自然主义运动涉及复杂的轨迹与不同的速度.
- 多巴胺在连续速度调制和元调制中的作用尚不清楚.
研究的目的:
- 研究多巴胺在自然运动中的速度调节和速度元调节中的作用.
- 检查多巴胺操纵如何影响运动轨迹的动力学特征.
主要方法:
- 研究一:帕金森病 (PD) 患者的运动动力学比较在使用和关闭多巴胺作用药物治疗 (N=32).
- 第二项研究:评估了接受利 (多巴胺抗剂) 和安慰剂 (N=43) 的健康个体的运动差异.
主要成果:
- 低多巴胺状况 (OFF药物,哈洛佩里多尔) 与运动速度降低有关.
- 多巴胺操纵影响了速度调节 (在拐角处减速) 和速度元调节 (形状依赖减速).
- 这些发现表明多巴胺在调节基于运动背景的速度方面的作用.
结论:
- 多巴胺不仅参与调节平均速度,还参与了运动过程中速度的动态调节.
- 这些发现超出了简单的活力模型,表明多巴胺参与了取决于环境的速度控制.
- 未来的研究应该探索多巴胺在连续速度调整中的精确机制.
相关概念视频
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
281
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
281
Drugs Affecting Neurotransmitter Synthesis
1.3K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.3K
Parkinson's Disease: Treatment
239
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
239
Adrenergic Agonists: Indirect-Acting Agents
1.5K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.5K
Direct-Acting Cholinergic Agonists: Pharmacological Actions
1.2K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
1.2K


